With support from Agilent Technologies, MGH researcher Robert Gerszten, MD, is tracking blood changes to help predict who needs early treatment for heart disease and diabetes.
Mass General team creates smartphone technology to obtain accurate information about penicillin allergies.
Biogen Foundation and the Cleary family have committed nearly half the funds needed to establish an endowed chair honoring former Neurology Chief Anne B. Young, MD, PhD.
The FDA approves the second phase of Dr. Denise Faustman’s clinical testing of a type 1 diabetes vaccine, an exciting next step in her pursuit of a therapy to reverse the disease.
After surviving a catastrophic cardiac event, Chris Toomey pays his luck forward by funding aortic dissection research at Mass General’s Thoracic Aortic Center.
Stand Up To Cancer and the American Cancer Society are funding a 3-year effort to combine the powers of targeted therapies with immunotherapies against a deadly form of lung cancer.
A charitable polo match is supporting the MGH Vaccine and Immunotherapy Center as it strives to transform promising research into livesaving products.
Elizabeth Thiele, MD, PhD, a world-renowned expert on tuberous sclerosis complex, says remarkable progress is being made in helping those with the disorder.
Getting treated for melanoma at the Mass General Cancer Center changed the odds for baseball legend MIke Schmidt.
Sparked by inexplicable symptoms in one patient, an intrepid physician’s investigation led to the discovery of a new disease that afflicts many worldwide.